H-2Kb MHC Tetramers: Building, Validating and Reading an Antigen-Specific CD8+ T Cell Stain

Before tetramers, counting antigen-specific T cells meant inferring them. A culture was restimulated, a cytokine was measured, and the frequency was estimated from a functional response. Cells that failed to respond were invisible, even when they were present.

MHC tetramer technology, developed in the late 1990s by John Altman, Mark Davis and colleagues, changed that. Antigen-specific T cells became directly visible and directly countable, which is why the method is treated as a milestone in cellular immunology rather than a convenient assay.

Why Tetramers Made Specific T Cells Countable

The underlying problem is affinity. A single T cell receptor binds a single peptide-MHC complex weakly, with a dissociation constant that allows rapid unbinding under flow conditions. Monomeric pMHC reagents therefore wash away before they can be measured.

Tetramers solve this geometrically. Four pMHC units are displayed on one fluorescent scaffold, so a T cell that engages several receptors at once gains avidity rather than affinity. The accumulated binding is strong enough to survive washing, and the cell becomes a detectable event.

Structural diagram of a T cell receptor engaging a peptide-loaded MHC class I molecule, showing the alpha and beta chains, the peptide binding groove and beta-2 microglobulin

The scaffold itself comes from an unusually strong natural interaction. Biotin binds streptavidin with a constant near 10^15 M^-1, which is effectively irreversible on the timescale of a staining experiment.

The Assembly Chemistry in Four Steps

Expression and refolding

The heavy and light chains of the chosen MHC class I molecule, for example mouse H-2Kb, are expressed recombinantly. A biotinylation substrate sequence recognised by the BirA enzyme is fused to the carboxy terminus of the heavy chain. The three components, heavy chain, β2-microglobulin and the specific peptide epitope, are then folded together in vitro to form a stable pMHC complex.

This refolding step is the least efficient part of the process. Buffer composition, temperature, time and the ratio of components all influence yield. Correctly folded complexes must then be separated from aggregates and unassembled material, typically by size exclusion chromatography.

Biotinylation

BirA then attaches biotin covalently to the substrate sequence at the heavy chain terminus. The reaction has to go to completion, because biotinylation efficiency sets the ceiling on tetramer yield. Unreacted free biotin must be removed afterwards by dialysis or a desalting column, otherwise it competes with the labelled pMHC for streptavidin binding sites.

Tetramerisation and polishing

Biotinylated pMHC is mixed with fluorescent streptavidin at a defined molar ratio. Each streptavidin carries four biotin-binding sites, so it assembles four pMHC units into one fluorescent tetramer. A final round of size exclusion chromatography or ultrafiltration removes free monomer and aggregates, leaving a homogeneous reagent.

Every stage is monitored. Sodium dodecyl sulfate polyacrylamide gel electrophoresis, high performance liquid chromatography, western blotting and analytical size exclusion chromatography are the standard release tests. Together they establish both potency and specificity of the final lot.

H-2Kb: The Mouse Allele That Carries the Literature

H-2Kb is an MHC class I allele from mouse strains such as C57BL/6, and it is one of the most widely used molecules in mouse immunology. A large share of the characterised viral, tumour and self epitopes in the mouse literature is presented by H-2Kb.

Two examples anchor the field. The gp33-41 peptide from lymphocytic choriomeningitis virus is the canonical reagent for studying acute and chronic viral infection. The SIINFEKL peptide from ovalbumin is the standard model antigen for vaccination and tumour immunology. Because both are so well described, a tetramer against either can be compared against decades of published frequencies.

What the Reagent Measures Better Than Functional Assays

Tetramer staining detects cells without restimulation, so the frequency obtained reflects the sample rather than the sample's capacity to respond. Peripheral blood, spleen, lymph node and tumour infiltrating lymphocytes can all be stained directly. The resulting percentages are more sensitive than enzyme-linked immunospot or intracellular cytokine staining in most comparisons.

The same tube can carry additional markers. Combining a tetramer with antibodies against CD62L, CD44, CD127 and KLRG1 separates naive cells, effector cells, memory precursors, terminal effectors, central memory and effector memory subsets. Phenotype and frequency then come from one acquisition.

Sorting extends the approach. Fluorescence-activated cell sorting on the tetramer signal yields live antigen-specific cells for cytotoxicity assays, proliferation tests, adoptive transfer, single-cell RNA sequencing or T cell receptor sequencing. That combination of enumeration and recovery is what functional assays cannot offer.

Four Failure Points

Peptide choice and affinity

The tetramer only works if the target clone recognises a peptide that H-2Kb actually presents. The peptide must be naturally processed and must bind the allele with enough affinity to form a stable complex. A low-affinity peptide produces an unstable reagent, which appears as high background or as a false negative.

Sample handling and staining conditions

Viability dominates. Dead cells bind tetramers and antibodies non-specifically and lift the background, so a viability dye belongs in every tube and gentle dissociation methods are preferred. Staining should be cold to prevent internalisation of the bound reagent.

Tetramers are large molecules, so incubation usually takes longer than a conventional antibody stain, typically 30 to 60 minutes at room temperature or one hour at 4 °C. The working concentration has to be titrated for each lot, and wash steps must be consistent across an experiment.

Gating and background

Positive populations can be extremely rare, and their fluorescence distribution can be wide. Setting the positive gate requires a control set rather than intuition. Three controls are standard.

An unimmunised sample or a tetramer loaded with an irrelevant peptide defines background binding. A peptide-pulsed sample, in which a known quantity of peptide is loaded onto cells from an unimmunised animal, provides a positive control. Pre-treatment with anti-CD8 or anti-TCR antibody should block binding, which demonstrates that the signal is receptor-specific.

Non-TCR binding

Some activated T cells and some subsets bind tetramers through mechanisms unrelated to the T cell receptor, including interactions with lectins. Fc receptor blocking and the appropriate controls identify these events, and without them a spurious population can survive every other check.

Where the Technology Is Going

Multicolour tetramers are the most visible trend. Streptavidin conjugated to different fluorophores, including PE, APC, BV421 and FITC, allows several specificities to be measured in one sample. Responses against multiple epitopes from one pathogen, or against several neoantigens from one tumour, can be resolved simultaneously.

Higher throughput comes from barcoding. Pools of dozens to hundreds of pMHC tetramers, each carrying a unique DNA barcode, stain a single sample. Tetramer-positive cells are sorted and the barcodes are read by sequencing, which reveals every specificity present in one pass.

Affinity and function are the third direction. Reversible streptavidin variants allow the tetramer to be released with free biotin after sorting, which limits interference with cell function. Dextran-backbone reagents carry more fluorophores and more pMHC units, improving sensitivity for low-affinity receptors. Combining tetramers with intracellular cytokine staining or transcription factor staining links specificity directly to function.

Available Tetramer Reagents

The panel spans viral surveillance and tumour immunology. The Epstein-Barr virus reagents cover latent and lytic antigens across several HLA alleles, which matters for studying responses in donors of different genetic backgrounds. The KRAS reagents target shared and mutation-specific neoepitopes, the setting where tetramer sensitivity is most valuable because the responding population is small.

A Practical Summary

A tetramer result is only as good as its controls. The chemistry is robust, the alleles are well characterised, and the fluorophores are bright. What decides whether a frequency is believable is the peptide, the viability of the sample, the titration of the reagent and the gate-setting logic.

Build the panel around those four items, and a tetramer becomes what it was designed to be: a direct count of the cells that recognise a defined antigen.

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

ANT BIO PTE. LTD. supplies high-quality reagents and solutions for life science research. Our sub-brands cover the full research workflow: Starter for antibodies and immunological assay kits, UA-Bio for recombinant proteins and drug discovery solutions, and Absin for general reagents and other detection kits. Explore our product portfolio at www.antbioinc.com.